VANCOUVER, BC / ACCESSWIRE / January 20, 2022 / Clairvoyant Therapeutics, a Canadian biotech company focused on the development of…
VANCOUVER, BC / ACCESSWIRE / January 20, 2022 / Goodbody Health Inc. (CSE:GDBY) ("Goodbody Health" or the "Company") is pleased…
Strong Company Momentum Advances Icario’s Mission of Making the World a Healthier PlaceMINNEAPOLIS, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Icario,…
Top-line data anticipated in the second quarter of 2022SAN DIEGO, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ:…
SAN DIEGO, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation…
– Live video webcast presentation on Tuesday, January 25that 9:00 AM ET PHILADELPHIA, PA, Jan. 20, 2022 (GLOBE NEWSWIRE) --…
Highlights Market Opportunity and Recent Accretive Acquisition Awarded Top 100 Premier Partner Status at Amazon World Services & Premier Partner Status…
JUPITER, Fla., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI),…
BOSTON, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics…
SHANGHAI, China and SUZHOU, China and GERMANTOWN, Md., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a global…